Method of preparing particularly skin-compatible cosmetic or dermatological cleansing preparations

ABSTRACT

The use of one or more cosurfactants (surfactant B) in a mixture with one or more surfactants different from surfactant B (surfactant A) for reducing the binding of surfactant A to the surface of the skin.

The present invention relates to a method of preparing particularlyskin-compatible cosmetic or dermatological cleansing preparations.

Preparations of this type are, for example, foam baths and showerpreparations, solid and liquid soaps or co-called “syndets” (syntheticdetergents), shampoos, handwash pastes, personal hygiene washingcompositions, special cleansers for small children and the like.

In a particular embodiment, the present invention relates to cleansingpreparations for use as shower preparations, bath preparations, bodycleansing and face cleansing.

Preparations of this type are also known per se. They are essentiallysurface-active substances or substance mixtures supplied to the consumerin a variety of preparations. Preparations of such type are generallydistinguished by a greater or lesser water content, but can also, forexample, be in the form of concentrate.

Even simple bathing in water without the addition of surfactants willinitially cause the horny layer of the skin to swell, the degree of thisswelling depending, for example, on the bathing time and temperature. Aswell as water-soluble substances, e.g. water-soluble constituents ofdirt, substances endogenous to the skin which are responsible for thewater-binding capacity of the horny layer are also washed off or out. Inaddition, as a result of surface-active substances endogenous to theskin, fats in the skin are also dissolved and washed out to a certaindegree. After the initial swelling, this causes a subsequent significantdrying-out of the skin, which may be further intensified bywashing-active additives.

In healthy skin, these processes are generally of no consequence sincethe protective mechanisms of the skin can readily compensate for suchslight disturbances to the upper layers of the skin. However, even inthe case of nonpathological deviations from the norm, e.g. as a resultof wear damage or irritation caused by the environment, photodamage,aging skin etc., the protective mechanism of the surface of the skin isimpaired. In some circumstances it is then no longer able to fulfill itsrole by itself and must be regenerated by external measures.

The object of the present invention was therefore to remedy theseshortcomings of the prior art. It was further an object of the inventionto provide bath or shower preparations which on the one hand have a highcare action, without, on the other hand, the cleansing action becominginferior.

Surface-active substances, the best known being the alkali metal saltsof higher fatty acids, i.e. the classical “soaps”—are amphiphilicsubstances which are able to emulsify or solubilize organic nonpolarsubstances in water.

These substances not only flush dirt from the skin and hair, theyirritate skin and mucous membranes to a greater or lesser extentdepending on the choice of surfactant or surfactant mixture.

One of the most commonly used surfactants for cosmetic compositionsthroughout the world is sodium lauryl ether sulfate. Although anexcellent washing-active agent with good foaming ability, in higherconcentrations it has an irritative effect on skin and mucous membranes.

As more recent investigations show, the irritancy potential of sodiumlauryl ether sulfate is at least partially promoted by the fact thatthis substance binds to the surface of the skin where it forms a certainreservoir. Studies suggest that lauryl ether sulfate from this reservoirpenetrates into the deeper layers of the skin, where it can then causeuncontrolled secondary reactions, which harbor an increased risk ofirritation.

Commercially available sodium lauryl ether sulfate (=sodiumpolyoxyethylene lauryl sulfate, according to INCI nomenclature: “Sodiumlaureth sulfate”; CAS No.1335-72-4), like most raw materials used incosmetics, is not a pure substance, but, depending on the preparation,is more likely a mixture of substances, the structures of which conformto the general formula

where n assumes numbers from 0 to 10 and m assumes numbers from 4 to 6.The lauryl ether derivative which predominates in the commericalproducts and gives them their name has m=5, n=2-3. Commercial productsare, for example, Texapon® N 25, Texapon® N 40, Texapon® N 70 andTexapon® N 103 from Henkel KGaA.

There are, however, also other lauryl ether sulfates which have, ascounterion, for example, unsubstituted ammonium ions or ammonium ionssubstituted by alkyl groups or hydroxyalkyl groups, but also magnesiumand such like.

However, because of the ready availability, the acceptable price and theexcellent washing properties of sodium lauryl ether sulfate, it will notbe possible in practice to dispense with this substance entirely in theforeseeable future. Although lauryl ether sulfate-free preparations areknown and entirely advantageous, they are characterized by otherperformance- or preparation-related or economic disadvantages.

The long-term application (for example longer than 1 hour) or repeatedshort-term application of anionic surfactants can lead to a reduction inskin moisture or to an increase in the transepidermal water loss (TEWL).

It is known per se to use sodium lauryl ether sulfate in combinationwith other surfactants as washing-active agent. The person skilled inthe art who would then like to increase the skin compatibility of suchpreparations then replaces some of the sodium lauryl ether sulfate withmilder surfactants. However, a reduction in foaming and/or cleansingperformance usually has to be accepted as an undesired side effect. Theaim was therefore to remedy this shortcoming.

In the attempt to increase the compatibility of lauryl ether sulfate onthe basis of scientific laws without replacing the surfactant withother, better tolerated surfactants (=cosurfactants), the person skilledin the art is faced with the following, as yet unresolved,contradiction:

The skin compatibility of surfactants correlates with the monomerconcentration/CMC of the surfactants. It does not increase further atconcentrations above the CMC.

Imokawa G, Mishima Y. Contact Dermatitis. 1979: 5: 357

Breuer M M. J Soc. Cosmet. Chem. 1979: 30: 41

The degree of skin damage increases with increasing surfactantconcentration—even above the CMC.

Wilhelm K P, Surber C, Maibach H I. Arch. Dermatol. Res. 1989: 281:293-295.

Because of this contradiction, it was not clear to the developer whichlaws can be used to prepare a milder formulation of a given surfactantsystem—in this case lauryl ether sulfate.

In various publications it has been speculated that there is aconnection between the skin reaction and the adsorption of surfactantson the skin. However, all of the investigations relating to theadsorption of surfactants on the skin have been carried out either

in vitro on substances with limited similarity to the human skin(callous powder, skin powder, isolated human or mammal Stratum corneum)

Dominguez J G, Parra J L, Infante M R, Pelejero C M, Balaguer F, SastreT. J Soc. Cosmet. Chem. 1977: 28: 165

Garret H E. Trans. of St. John's Hosp. Dermatol. Soc. 1965: 51: 166

Faucher J A, Goddard E D. J Soc. Cosmet. Chem. 1978: 29: 323

Gibson W T, Teall M R. Fd Chem. Toxic. 1982: 21: 581

ex vivo (excised human or mammal skin)

Fullerton A, Broby-Johansen U, Agner T. Contact Dermatitis. 1994: 30:222

or

in vivo using inadequate, irrelevant, due to being application-remote,or nonvalidated methods (indirect dyeing methods, extraction with wateror acetone)

Imokawa G, Mishima Y. Contact Dermatitis. 1979: 5: 357.

Adsorption measurements carried out under equilibrium conditions(long-term application) are of no relevance for application conditions(showering). Measurements described in the literature do not thereforeadequately reflect the application situation and therefore producedirrelevant results.

At the 2^(nd) Scientific Conference of the Asian Societies of CosmeticScientists, 1995, in Seoul, a paper entitled “Development of High-SafetyFacial Cleansers through Reduction of Cutaneous Surfactant Adsorption”was presented which dealt with a theme related to the present invention.

However, the “facial cleansers” are soap products which, however, arenot intended to be the subject of our patent. Although soaps are alsoanionic surfactants, they can only develop their surface-active actionat a high pH. Upon contact with the skin, soaps can lose their basicityas a result of the buffering action of the skin and as a result losetheir soap character. The synthetic detergents on which we focus do nothave this peculiarity.

By virtue of this limitation, soaps exhibit unique characteristics and,when compared with synthetic detergents such as lauryl ether sulfate orSLS, are to be regarded as an independent product class.

The method which we have developed for determining the adsorption oflauryl ether sulfate on the skin simulates a washing operation asoccurs, for example, during daily showering:

Firstly, the inner sides of the forearms are divided into a number oftest areas using insulating tape. The area to be treated is then wettedwith approximately 50 ml of mains water (T=38±1° C.). The lauryl ethersulfate is then applied. Throughout the application period of 45 s, thetest subject distributes the lauryl ether sulfate over the area using 2fingers in uniform circular movements. At the end of the applicationperiod, the test area is rinsed with approximately 950 ml of mains water(T=38±1° C.) and carefully patted dry using a clean cellulose cloth. Forthe desorption, a plastic ring with an internal diameter of 25 mm ispressed firmly onto the inner side of the test subject's forearm. 1000μl of a 1% Triton X-100 solution are then introduced into the ring. Thetip of a round Teflon-coated spatula is then used to scrape the skinuniformly for 1 min. This leads to suspension of corneocytes. To work upthe samples for analysis, the samples are centrifuged and 800 μl of thesupernatant are drawn off. The supernatant is analyzed with regard toits lauryl ether sulfate content using ion-pair chromatography. Theeffectiveness of the desorption method described is 79%, i.e. 79% of theamount of lauryl ether sulfate actually present on the skin areincluded.

The results of the experiments for the adsorption of lauryl ethersulfate show that sodium lauryl ether sulfate adsorbs/binds to thesurface of the skin during washing operations under use conditions.

Surprisingly, the amount of surfactant adsorbed to the surface of theskin under use conditions further increases even above the maximumachievable monomer concentration (CMC). FIG. 1 shows the adsorbed amountof lauryl ether sulfate as a function of the lauryl ether sulfateconcentration. The CMC of the lauryl ether sulfate used is between 0.01and 0.1% by weight.

The object of the present invention was therefore to remedy theshortcomings uncovered.

Surprisingly, and herein lies the basis of the solution, theshortcomings are overcome according to the invention through the use ofone or more cosurfactants (surfactant B) which do not correspond to thesurfactant sodium lauryl ether sulfate in a mixture with the surfactantsodium lauryl ether sulfate for reducing the binding of surfactant A tothe surface of the skin.

The invention further relates to the use of one or more cosurfactants(surfactant B) for the preparation of mild washing-active cosmetic ordermatological preparations with a further content of one or morewashing-active surfactants, which have a tendency to bind to the surfaceof the skin (surfactant A), which, when used, achieve a decrease in orprevention of the binding of surfactant A to the surface of the skin.

In a particular embodiment, the present invention relates towashing-active hair cosmetic preparations, commonly referred to asshampoos. In particular, the present invention relates to hair cosmeticactive ingredient combinations and preparations for the care of thescalp.

Surprisingly and unforeseeable by the person skilled in the art, it hasbeen found that the addition of cosurfactants to lauryl ether sulfateleads to a reduction in the amount of lauryl ether sulfate adsorbed onthe skin. Skin compatibility studies carried out in parallel demonstratethe increased mildness of the products as a result of the addition ofcosurfactants.

Table 1 shows the reduction in the adsorption of lauryl ether sulfate asa result of the addition of different cosurfactants to a lauryl ethersulfate solution.

TABLE 1 Cosur- factant Effect on the adsorbed con- amount of laurylether Signi- Cosurfactant centration sulfate ficance Sodium lauroylglutamate 1.5% Reduction by 31% Yes Disodium laureth 3% Reduction by 28%Yes sulfosuccinate Sodium lauroyl sarcosinate 3% Reduction by 23% YesSodium cocoamphoacetate 3% Reduction by 27% Yes Cocamidopropylbetaine 3%Reduction by 31% Yes Decyl glucoside 5% Reduction by 29% Yes Lauricacid, pH9 1% Reduction by 15% Yes

This result is all the more surprising since the addition of one or morecosurfactants leads to an increase in the active content of surfactantsin the formulation. The person skilled in the art would expect areduction in skin mildness as a result of this increase inconcentration.

Surprisingly, the opposite result was found: the increase in the overallsurfactant concentration led to an increase in the mildness of theproducts.

A further embodiment of the present invention relates to the use of oneor more cosurfactants (surfactant B) in a mixture with one or moresurfactants which differ from surfactant B (surfactant A) for decreasingthe binding of surfactant A to the surface of the skin.

FIG. 2 shows the reduction in the adsorption of lauryl ether sulfate asa result of the addition of various cosurfactants to a lauryl ethersulfate solution. Here, LES means sodium lauryl ether sulfate. NLG meanssodium lauroyl glutamate. CAPB means cocamidopropylbetaine. DPG meansdecyl polyglucoside.

For example, the present invention manifests itself in washing-activecosmetic or dermatological preparations comprising:

(a) more than 9.0% by weight of lauryl ether sulfate,

(b) one or more anionic surfactants chosen from the group of N-acylaminoacids and salts thereof,

(c) other surfactants, such as cocamidopropyl betaine, decyl or dodecylpolyglucoside, disodium laureth sulfosuccinate, sodium lauroylsarcosinate, trilaureth 4-phosphate, sodium cocoamphoacetate, disodiumcocoamphoacetate,

(d) less than 5.0% by weight of inorganic salts.

The present invention is also realized by washing-active cosmetic ordermatological preparations comprising:

(a) more than 9.0% by weight of lauryl ether sulfate,

(b) more than 1.0% by weight, in particular more than 1.75% by weight ofone or more anionic surfactants chosen from the group of N-acylaminoacids and salts thereof,

(c) less than 5.0% by weight of inorganic salts.

Surfactant B can advantageously be chosen from the group of N-acylaminoacids and salts thereof, this surfactant or these surfactants beingpresent in washing-active cosmetic or dermatological preparations inconcentrations greater than 3.0% by weight, based on the total weight ofthe preparations, for reducing the attachment of lauryl ether sulfate tohuman skin during the washing operation or for removing lauryl ethersulfate from human skin.

It is known per se that N-acylamino acids and salts thereof are mildsurfactants with a useful foaming action and good washing action (H. P.Fiedler, Lexikon der Hilfsstoffe für Pharmazie, Kosmetik und angrenzendeGebiete [Lexicon of auxiliaries for pharmacy, cosmetics and relatedfields], 4^(th) edition, p. 108, keyword “N-Acylglutaminsäure”[N-acylglutamic acid]).

The paper “Surface Active N-Acylglutamate: Preparation of Long ChainN-Acylglutamic Acid” (M. Takehara, I. Yoshimura, K. Takizawa, R.Yoshida; Journal of the American Oil Chemists' Society Vol.49, p.157ff.) cites JP Patent 29 444 (1964), according to which acyl glutamatesare said to alleviate skin irritations caused by other anionicsurfactants such as sodium alkylbenzenesulfonates and sodium laurylsulfate.

DE-A 43 04 066 describes a preparation with a content of 12% by weightof sodium lauryl ether sulfate and 3% by weight of sodium cocoylglutamate. However, the subject-matter of this specification is the useof electrolytes for preventing the penetration of the surface-activesubstances present in the cleansing compositions and/or other substancespresent in these cleansing compositions into the external layers of theskin—in the preparation mentioned above, 8% by weight of sodium chlorideare also present to whose presence the person skilled in the artattributes the reduction in the irritancy potential of the sodium laurylether sulfate.

The acylamino acids (where, within the scope of the present disclosure,the acylpeptides are also classed as acylamino acids) or salts thereofmay advantageously be chosen from the group

1. acyl glutamates, for example sodium acyl glutamates, di-TEA palmitoylaspartate and sodium caprylic acid/capric acid glutamate,

2. acyl peptides, for example palmitoyl-hydrolyzed milk protein, sodiumcocoyl-hydrolyzed soy protein and sodium/potassium cocoyl-hydrolyzedcollagen,

3. sarcosinates, for example myristoyl sarcosine, TEAlauroylsarcosinate, sodium lauroylsarcosinate and sodiumcocoylsarcosinate,

4. taurates, for example sodium lauroyl taurate and sodium methyl cocoyltaurate,

5. acyl lysinates, for example lauroyl lysine

6. acyl alaninates

7. acyl glycinates

Also, the cosurfactants below may have an advantageous effect:

1. cocamidopropyl betaine

2. decyl polyglucoside

3. dodecyl polyglucoside

4. disodium laureth sulfosuccinate

5. sodium lauroyl sarcosinate

6. trilaureth 4-phosphate

7. sodium cocoamphoacetate

8. disodium cocoamphoacetate.

For the purposes of the present invention, it is particularlyadvantageous to use, as acylamino acid or salts thereof, acylglutamicacid, or acyl glutamates, in particular sodium acyl glutamates, whichare characterized by the following structures:

Of the sodium acyl glutamates in turn, sodium cocoyl glutamate, sodiumlauroyl glutamate, sodium myristoyl glutamate, sodium stearoyl glutamateand sodium tallowyl glutamate have proven particularly advantageous.

Apart from the abovementioned surfactants, the compositions optionallycomprise, according to the invention, the additives customary incosmetics, for example perfumes, dyes, antimicrobial substances,refatting agents, complexing and sequestering agents, pearlizing agents,plant extracts, vitamins, active ingredients, preservatives,bactericides, pigments which have a coloring action, thickeners,emollients, moisturizers and/or humectants, fats, oils, waxes or othercustomary constituents of a cosmetic or dermatological formulation, suchas alcohols, polyols, polymers, foam stabilizers, electrolytes, organicsolvents or silicone derivatives.

The examples below serve to illustrate the present invention withoutlimiting it. Unless stated otherwise, all amounts, proportions andpercentages are by weight, based on the weight and the total amount oron the total weight of the preparations.

EXAMPLE 1

% by weight Sodium laureth sulfate (27.5% strength solution) 48.00Cocoamidopropylbetaine (33% strength solution) 5.00 Sodium cocoylglutamate (25% strength solution) 5.00 PEG-40 hydrogenated castor oil0.50 PEG-100 hydrogenated glyceryl palmitate 0.50 Sodium benzoate 0.45Sodium salicylate 0.20 Citric acid 0.50 Perfume q.s. Water ad 100.00

The constituents are combined at room temperature and stirred to give ahomogeneous mixture.

EXAMPLE 2

% by weight Sodium laureth sulfate (27.5% strength solution) 40.00Cocoamidopropylbetaine (33% strength solution) 10.00 Sodium cocoylglutamate (25% strength solution) 8.00 PEG-40 hydrogenated castor oil0.50 PEG-100 hydrogenated glyceryl palmitate 0.50 Sodium benzoate 0.45Sodium salicylate 0.20 Citric acid 0.50 Perfume q.s. Water ad 100.00

The constituents are combined at room temperature and stirred to give ahomogeneous mixture.

EXAMPLE 3

% by weight Sodium laureth sulfate (27.5% strength solution) 30.00Cocoamidopropylbetaine (33% strength solution) 15.00 Sodium cocoylglutamate (25% strength solution) 4.50 PEG-40 hydrogenated castor oil0.50 PEG-100 hydrogenated glyceryl palmitate 0.50 Sodium benzoate 0.45Sodium salicylate 0.20 Citric acid 0.50 Perfume q.s. Water ad 100.00

The constituents are combined at room temperature and stirred to give ahomogeneous mixture.

EXAMPLE 4

% by weight Sodium laureth sulfate (27.5% strength solution) 43.00Cocoamidopropylbetaine (33% strength solution) 11.00 Sodium cocoylglutamate (25% strength solution) 4.50 Decyl glucoside (50% strengthsolution) 2.00 PEG-40 hydrogenated castor oil 0.50 PEG-100 hydrogenatedglyceryl palmitate 0.50 Sodium benzoate 0.45 Sodium salicylate 0.20Citric acid 0.50 Perfume q.s. Water ad 100.00

The constituents are combined at room temperature and stirred to give ahomogeneous mixture.

EXAMPLE 5

% by weight Sodium laureth sulfate (27.5% strength solution) 35.00Cocoamidopropylbetaine (33% strength solution) 8.00 Sodium cocoylglutamate (25% strength solution) 5.00 Decyl glucoside (50% strengthsolution) 4.00 PEG-40 hydrogenated castor oil 0.50 PEG-100 hydrogenatedglyceryl palmitate 0.50 Sodium benzoate 0.45 Sodium salicylate 0.20Citric acid 0.50 Perfume q.s. Water ad 100.00

The constituents are combined at room temperature and stirred to give ahomogeneous mixture.

EXAMPLE 6

% by weight Sodium laureth sulfate (27.5% strength solution) 25.00Cocoamidopropylbetaine (33% strength solution) 14.00 Sodium cocoylglutamate (25% strength solution) 6.00 Decyl glucoside (50% strengthsolution) 3.00 PEG-40 hydrogenated castor oil 0.50 PEG-100 hydrogenatedglyceryl palmitate 0.50 Sodium benzoate 0.45 Sodium salicylate 0.20Citric acid 0.50 Perfume q.s. Water ad 100.00

The constituents are combined at room temperature and stirred to give ahomogeneous mixture.

EXAMPLE 7

% by weight Sodium laureth sulfate (27.5% strength solution) 47.00Sodium cocoamphoacetate (36% strength solution) 9.00 Sodium cocoylglutamate (25% strength solution) 6.00 PEG-40 hydrogenated castor oil0.50 PEG-100 hydrogenated glyceryl palmitate 0.50 Sodium benzoate 0.45Sodium salicylate 0.20 Citric acid 0.50 Perfume q.s. Water ad 100.00

The constituents are combined at room temperature and stirred to give ahomogeneous mixture.

EXAMPLE 8

% by weight Sodium laureth sulfate (27.5% strength solution) 41.00Sodium cocoamphoacetate (36% strength solution) 6.50 Sodium cocoylglutamate (25% strength solution) 7.50 PEG-40 hydrogenated castor oil0.50 PEG-100 hydrogenated glyceryl palmitate 0.50 Sodium benzoate 0.45Sodium salicylate 0.20 Citric acid 0.50 Perfume q.s. Water ad 100.00

The constituents are combined at room temperature and stirred to give ahomogeneous mixture.

EXAMPLE 9

% by weight Sodium laureth sulfate (27.5% strength solution) 41.00Sodium cocoamphoacetate (36% strength solution) 6.50 Sodium lauroylglutamate (25% strength solution) 5.50 PEG-40 hydrogenated castor oil0.50 PEG-100 hydrogenated glyceryl palmitate 0.50 Sodium benzoate 0.45Sodium salicylate 0.20 Citric acid 0.50 Perfume q.s. Water ad 100.00

The constituents are combined at room temperature and stirred to give ahomogeneous mixture.

EXAMPLE 10

% by weight Sodium laureth sulfate (27.5% strength solution) 32.00Sodium cocoamphoacetate (36% strength solution) 5.00 Sodium cocoylglutamate (25% strength solution) 5.00 PEG-40 hydrogenated castor oil0.50 PEG-100 hydrogenated glyceryl palmitate 0.50 Sodium benzoate 0.45Sodium salicylate 0.20 Citric acid 0.50 Perfume q.s. Water ad 100.00

The constituents are combined at room temperature and stirred to give ahomogeneous mixture.

What is claimed is:
 1. A method for reducing the binding of a sodiumlauryl ether sulfate surfactant to the surface of the skin thatcomprises: selecting a co-surfactant which decreases or prevents bindingby mixing a co-surfactant with the sodium lauryl ether sulfatesurfactant before contacting the sodium lauryl ether sulfate surfactantwith the surface of the skin, wherein the co-surfactant is not sodiumlauryl ether sulfate surfactant and wherein the co-surfactant binds tothe surface of the skin, thus achieving a predetermined decrease in orprevention of the binding of the sodium lauryl ether sulfate surfactantto the surface of the skin.
 2. A method for preparing a mildwashing-active cosmetic or dermatological preparation that comprises:selecting a cc-surfactant which decreases or prevents binding by mixinga co-surfactant with an anionic sodium lauryl ether sulfate surfactantto form a mild washing-active cosmetic or dermatological preparation,wherein the co-surfactant is not anionic sodium lauryl ether sulfate andwherein the co-surfactant binds to the surface of the skin, thusachieving a predetermined decrease in or prevention of the binding ofthe sodium lauryl ether sulfate surfactant to the surface of the skinwhen the preparation is applied to the skin.
 3. The method according toclaim 1, wherein the co-surfactant is selected from the group consistingof anionic N-acylamino acids, salts of anionic N-acylamino acids, andmixtures thereof.
 4. The method according to claim 3, wherein theco-surfactant is selected from the group consisting of acyl glutamates,acyl peptides, sarcosinates, taurates, acyl lysinates, acyl alaninates,acyl glycinates, betaines, amphoacetates, polyglucosides, andsulfosuccinates.
 5. The method according to claim 3, wherein theco-surfactant is trilaureth-4 phosphate.
 6. The method according toclaim 4, wherein the co-surfactant is selected from the group consistingof sodium acyl glutamate, di-TEA palmitoyl aspartate, sodium caprylicacid, capric acid glutamate, and mixtures thereof.
 7. The methodaccording to claim 4, wherein the co-surfactant is selected from thegroup consisting of palmitoyl-hydrolyzed milk protein, sodiumcocoyl-hydrolyzed soy protein, sodium cocoyl-hydrolyzed collagen,potassium cocyl-hydrolyzed collagen, and mixtures thereof.
 8. The methodaccording to claim 4, wherein the co-surfactant is selected from thegroup consisting of myristoyl sarcosine, TEA lauroyl sarcosinate, sodiumlauroyl sarcosinate, sodium cocoyl sarcosinate, and mixtures thereof. 9.The method according to claim 4, wherein the co-surfactant is selectedfrom the group consisting of sodium lauroyl taurate, sodium methylcocoyl taurate, and mixtures thereof.
 10. The method according to claim4, wherein the co-surfactant is lauroyl lysine.
 11. The method accordingto claim 4, wherein the co-surfactant is an acyl alaninate or mixturethereof.
 12. The method according to claim 4, wherein the co-surfactantis an acyl glycinate or mixture thereof.
 13. The method according toclaim 4, wherein the co-surfactant is a cocamidopropylbetaine or mixturethereof.
 14. The method according to claim 4, wherein the co-surfactantis selected from the group consisting of sodium cocoamphoacetate,disodium cocoamphoacetate, or mixtures thereof.
 15. The method accordingto claim 4, wherein the co-surfactant is selected from the groupconsisting of decyl polyglucosides, dodecyl polyglucosides, or mixturesthereof.
 16. The method according to claim 4, wherein the co-surfactantis disodium lauroyl sulfosuccinate.